Systematic characterisation of disease associated balanced chromosome rearrangements by FISH: cytogenetically and genetically anchored YACs identify microdeletions and candidate regions for mental retardation genes. 1999

J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
Max Planck Institute of Molecular Genetics, Berlin, Germany.

Disease associated balanced chromosome rearrangements (DBCRs) have been instrumental in the isolation of many disease genes. To facilitate the molecular cytogenetic characterisation of DBCRs, we have generated a set of >1200 non-chimeric, cytogenetically and genetically anchored CEPH YACs, on average one per 3 cM, spaced over the entire human genome. By fluorescence in situ hybridisation (FISH), we have performed a systematic search for YACs spanning translocation breakpoints. Patients with DBCRs and either syndromic or non-syndromic mental retardation (MR) were ascertained through the Mendelian Cytogenetics Network (MCN), a collaborative effort of, at present, 270 cytogenetic laboratories throughout the world. In this pilot study, we have characterised 10 different MR associated chromosome regions delineating candidate regions for MR. Five of these regions are narrowed to breakpoint spanning YACs, three of which are located on chromosomes 13q21, 13q22, and 13q32, respectively, one on chromosome 4p14, and one on 6q25. In two out of six DBCRs, we found cytogenetically cryptic deletions of 3-5 Mb on one or both translocation chromosomes. Thus, cryptic deletions may be an important cause of disease in seemingly balanced chromosome rearrangements that are associated with a disease phenotype. Our region specific FISH probes, which are available to MCN members, can be a powerful tool in clinical cytogenetics and positional cloning.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002882 Chromosomes, Human, Pair 13 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 13
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions

Related Publications

J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
March 1977, American journal of human genetics,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
February 1998, Journal of medical genetics,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
June 2004, Clinical genetics,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
March 2007, Neurology,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
January 2004, American journal of medical genetics. Part A,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
January 2003, Annales de genetique,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
January 2004, Epilepsy currents,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
February 2006, BMC genomics,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
February 2008, BMC genomics,
J Wirth, and H G Nothwang, and S van der Maarel, and C Menzel, and G Borck, and I Lopez-Pajares, and K Brøndum-Nielsen, and N Tommerup, and M Bugge, and H H Ropers, and T Haaf
January 2003, Journal of cellular and molecular medicine,
Copied contents to your clipboard!